Plain-English translation of NCT07115914 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether a special type of imaging scan called PSMA PET can help doctors better monitor prostate cancer after focal therapy. Focal therapy is a treatment where doctors destroy only the cancerous part of your prostate while leaving the rest of the gland intact. The study will follow you for about 12 months after your focal therapy to see if this scanning technique helps catch any cancer recurrence early.
After focal therapy, doctors need better ways to know if cancer has come back. This imaging scan might be more accurate at detecting any remaining or returning cancer compared to traditional monitoring methods, which could help catch problems sooner.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have study visits over about 12 months after your focal therapy. You'll receive a special PET scan (in addition to your regular follow-up MRI and biopsy) to help doctors monitor your cancer. You'll also be asked to give blood and urine samples for research, and optionally provide a tissue sample; you'll complete questionnaires about your quality of life throughout the study.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States